May New Remedy for Meals ‘Cues’ Enhance Weight Loss?
An intensive 1-year habits remedy program aimed toward altering an individual’s response to meals “cues” would
Therapy
FDA Grants Regenerative Medication Superior Remedy (RMAT) designation to Autolus’ CAR T cell remedy, obe-cel, for the remedy of grownup B-ALL
Autolus Restricted LONDON, April 25, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a
European Medicines Company Commences Evaluation of Novel Gene Remedy Candidate Etranacogene Dezaparvovec for Individuals with Hemophilia B
Advertising and marketing Authorization Software (MAA) for etranacogene dezaparvovec might be reviewed beneath accelerated evaluation